IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GENNARELLI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.780
AS - Asia 10.516
EU - Europa 8.867
SA - Sud America 2.276
Continente sconosciuto - Info sul continente non disponibili 571
AF - Africa 251
OC - Oceania 33
AN - Antartide 1
Totale 47.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.122
CN - Cina 3.744
SG - Singapore 3.308
UA - Ucraina 2.000
BR - Brasile 1.857
IT - Italia 1.466
HK - Hong Kong 1.165
PL - Polonia 1.136
DE - Germania 1.103
FR - Francia 781
VN - Vietnam 769
GB - Regno Unito 616
FI - Finlandia 605
TR - Turchia 375
BD - Bangladesh 365
RU - Federazione Russa 355
IE - Irlanda 328
CA - Canada 314
IN - India 236
AR - Argentina 169
MX - Messico 122
ZA - Sudafrica 80
ID - Indonesia 74
IQ - Iraq 70
SE - Svezia 69
NL - Olanda 62
ES - Italia 61
EC - Ecuador 58
PK - Pakistan 55
CO - Colombia 50
JP - Giappone 48
LT - Lituania 47
VE - Venezuela 47
BE - Belgio 44
CZ - Repubblica Ceca 43
AT - Austria 41
SA - Arabia Saudita 38
MA - Marocco 35
CL - Cile 33
CR - Costa Rica 32
JM - Giamaica 31
AU - Australia 29
PY - Paraguay 28
HN - Honduras 27
IL - Israele 27
NG - Nigeria 26
TT - Trinidad e Tobago 25
KE - Kenya 24
UZ - Uzbekistan 24
CH - Svizzera 22
IR - Iran 22
EU - Europa 21
GT - Guatemala 21
JO - Giordania 21
PH - Filippine 20
EG - Egitto 19
PR - Porto Rico 19
PE - Perù 17
NP - Nepal 16
SV - El Salvador 16
AE - Emirati Arabi Uniti 15
TN - Tunisia 15
KR - Corea 13
EE - Estonia 12
MY - Malesia 12
AZ - Azerbaigian 10
BB - Barbados 10
BG - Bulgaria 10
BH - Bahrain 10
CW - ???statistics.table.value.countryCode.CW??? 10
KG - Kirghizistan 10
KZ - Kazakistan 10
NI - Nicaragua 10
SC - Seychelles 10
UY - Uruguay 10
DZ - Algeria 9
HU - Ungheria 9
OM - Oman 9
PA - Panama 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
MU - Mauritius 8
RO - Romania 8
AL - Albania 7
TW - Taiwan 7
DK - Danimarca 6
LV - Lettonia 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
BS - Bahamas 5
BY - Bielorussia 5
GE - Georgia 5
KW - Kuwait 5
LB - Libano 5
PT - Portogallo 5
TH - Thailandia 5
AO - Angola 4
LU - Lussemburgo 4
NO - Norvegia 4
PS - Palestinian Territory 4
Totale 46.701
Salva come PNG Salva come JPEG
Città #
Fairfield 2.492
Ashburn 2.244
Woodbridge 1.992
Singapore 1.823
Jacksonville 1.434
Houston 1.295
San Jose 1.162
Hong Kong 1.157
Warsaw 1.127
Ann Arbor 1.076
Cambridge 1.009
Seattle 948
Wilmington 832
Chandler 654
Beijing 641
Council Bluffs 626
Princeton 603
The Dalles 600
Nanjing 517
New York 462
Los Angeles 375
Brescia 327
Dublin 324
Lauterbourg 304
Istanbul 295
Columbus 291
Helsinki 288
Ho Chi Minh City 268
Dearborn 230
Nanchang 212
Des Moines 207
São Paulo 200
Milan 187
Buffalo 176
Munich 171
Santa Clara 166
Shenyang 157
Dallas 155
Changsha 143
Hebei 139
Chicago 138
Hanoi 138
San Diego 138
San Francisco 129
Moscow 126
Shanghai 126
Redondo Beach 115
Lancaster 107
Jinan 104
Tianjin 94
Jiaxing 86
Orem 86
Toronto 82
London 81
Phoenix 72
Verona 71
Dong Ket 68
North Bergen 68
Hangzhou 65
Montreal 65
Boardman 64
Kunming 64
Frankfurt am Main 61
Turku 61
Rome 59
Brooklyn 58
Norwalk 58
Denver 57
Atlanta 55
Guangzhou 54
Nuremberg 53
Rio de Janeiro 53
Zhengzhou 52
Mexico City 51
Lanzhou 50
Naples 48
Ningbo 48
Belo Horizonte 47
Johannesburg 44
Brussels 42
Tokyo 41
Haikou 39
Brasília 36
Haiphong 36
San Mateo 35
Romola 34
Bolzano 33
Stockholm 32
Washington 31
Chennai 30
Jakarta 30
Manchester 30
Charlotte 29
Leawood 27
Brno 26
Dhaka 26
Salt Lake City 26
San José 26
Vilnius 26
Abuja 25
Totale 30.965
Salva come PNG Salva come JPEG
Nome #
Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. 475
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 341
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 335
New Copy Number Variations in Schizophrenia 332
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 313
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 278
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 274
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 259
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 257
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 253
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 251
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 244
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 240
New biological pathways for major depression: gene expression decomposition in G x E components 224
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 223
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients 223
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 220
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 219
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 214
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. 208
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 207
Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. 202
The role of the potassium channel gene KCNK2 in major depressive disorder 202
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 201
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 200
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 195
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 195
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 195
A genome-wide investigation of SNPs and CNVs in schizophrenia. 194
Analysis of Copy Number Variations in Schizophrenia Italian Patients 192
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 191
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 190
Next Generation Sequencing Analysis in Early Onset Dementia Patients 189
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 188
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. 187
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. 186
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 186
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets' 184
The role of GRIK4 gene in treatment-resistant depression 184
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. 182
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 182
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 181
Glucose metabolism alterations in patients with bipolar disorder 180
BDNF Val66Met polymorphism and protein levels in amniotic fluid. 179
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 179
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 178
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study. 178
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 176
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study 175
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. 175
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 173
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 172
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study. 172
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial. 170
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 170
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine. 169
Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. 169
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. 168
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 167
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. 167
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 166
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 165
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 165
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 165
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 164
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 163
Dementia, delusions and seizures: storage disease or genetic AD? 162
PCLO gene: Its role in vulnerability to major depressive disorder. 161
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 160
Blood microRNA changes in depressed patients during antidepressant treatment. 160
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 160
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 158
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. 158
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 158
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 156
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 156
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series 156
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 155
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 155
VEGF Haplotypes are Associated with Increased Risk to Progressive Supranuclear Palsy and Corticobasal Syndrome. 154
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). 154
Immune and metabolic alterations in first episode psychosis (FEP) patients 154
Genetic variations and association. 153
Erbb3 leukocytes mRNA levels as biomarker of Major Depression. 153
Heterozygous TREM2 mutations in frontotemporal dementia 153
Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients 153
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate. 152
EXPLORING LRRK2 BIOLOGY IN GLIAL CELLS: IMPLICATION FOR PARKINSON’S DISEASE 152
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 152
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment. 152
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence. 151
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 151
(CTG)n TRIPLET MUTATION AND PHENOTYPE MANIFESTATIONS IN MYOTONIC DYSTROPHY PATIENTS. 150
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 150
A single polymerase chain reaction-based protocol for detecting normal and expanded alleles in myotonic dystrophy. 149
INFLAMMATORY AND NEUROTROPHIC FACTORS UNBALANCE IN LEUKOCYTES OF FIRST EPISODE PSYCHOSIS PATIENTS 149
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 149
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 148
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation. 148
Exome sequencing of schizophrenia patients with high level of homozygosity identifies a homozygous novel mutation that reduces the glutamate acid decarboxylase 67 (GAD67) activity 148
Totale 18.931
Salva come PNG Salva come JPEG
Categoria #
all - tutte 227.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.623
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.641 0 0 0 56 14 98 206 142 172 238 206 509
2022/20232.084 349 12 31 146 190 620 6 208 315 32 94 81
2023/20242.135 127 52 188 131 95 349 60 72 588 37 37 399
2024/20255.439 47 55 82 615 592 516 392 189 513 585 1.034 819
2025/202611.700 1.042 1.622 852 1.769 1.142 762 1.602 471 725 930 497 286
2026/20274.426 605 830 1.264 1.727 0 0 0 0 0 0 0 0
Totale 47.295